The global eosinophilic granulomatosis with polyangiitis treatment industry demand, valued at US$ 173.8 Million in 2023, is poised for substantial growth at a CAGR of 5.2%. A comprehensive market analysis forecasts an impressive escalation, driven by technological advances in healthcare, reaching an estimated US$ 288.5 Million by 2033. Several factors contribute to this anticipated growth, …